2bxc: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
[[Image:2bxc.gif|left|200px]]
[[Image:2bxc.gif|left|200px]]


{{Structure
<!--
|PDB= 2bxc |SIZE=350|CAPTION= <scene name='initialview01'>2bxc</scene>, resolution 3.10&Aring;
The line below this paragraph, containing "STRUCTURE_2bxc", creates the "Structure Box" on the page.
|SITE= <scene name='pdbsite=AC1:P1z+Binding+Site+For+Chain+B'>AC1</scene>
You may change the PDB parameter (which sets the PDB file loaded into the applet)
|LIGAND= <scene name='pdbligand=P1Z:4-BUTYL-1,2-DIPHENYL-PYRAZOLIDINE-3,5-DIONE'>P1Z</scene>
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
|ACTIVITY=  
or leave the SCENE parameter empty for the default display.
|GENE=  
-->
|DOMAIN=
{{STRUCTURE_2bxc| PDB=2bxc  | SCENE= }}  
|RELATEDENTRY=
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2bxc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2bxc OCA], [http://www.ebi.ac.uk/pdbsum/2bxc PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2bxc RCSB]</span>
}}


'''HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE'''
'''HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE'''
Line 30: Line 27:
[[Category: Petitpas, I.]]
[[Category: Petitpas, I.]]
[[Category: Zunszain, P A.]]
[[Category: Zunszain, P A.]]
[[Category: metal-binding,drug-binding,phenylbutazone]]
[[Category: Metal-binding,drug-binding,phenylbutazone]]
[[Category: transport protein,albumin,carrier protein,lipid-binding]]
[[Category: Transport protein,albumin,carrier protein,lipid-binding]]
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 20:55:45 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 02:13:10 2008''

Revision as of 20:55, 3 May 2008

File:2bxc.gif

Template:STRUCTURE 2bxc

HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE


OverviewOverview

Human serum albumin (HSA) is an abundant plasma protein that binds a remarkably wide range of drugs, thereby restricting their free, active concentrations. The problem of overcoming the binding affinity of lead compounds for HSA represents a major challenge in drug development. Crystallographic analysis of 17 different complexes of HSA with a wide variety of drugs and small-molecule toxins reveals the precise architecture of the two primary drug-binding sites on the protein, identifying residues that are key determinants of binding specificity and illuminating the capacity of both pockets for flexible accommodation. Numerous secondary binding sites for drugs distributed across the protein have also been identified. The binding of fatty acids, the primary physiological ligand for the protein, is shown to alter the polarity and increase the volume of drug site 1. These results clarify the interpretation of accumulated drug binding data and provide a valuable template for design efforts to modulate the interaction with HSA.

About this StructureAbout this Structure

2BXC is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

Structural basis of the drug-binding specificity of human serum albumin., Ghuman J, Zunszain PA, Petitpas I, Bhattacharya AA, Otagiri M, Curry S, J Mol Biol. 2005 Oct 14;353(1):38-52. PMID:16169013 Page seeded by OCA on Sat May 3 20:55:45 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA